ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity

View Author Information
Department of Pathology and Bosch Institute, University of Sydney, Sydney, NSW 2006, Australia
Centre for Metals in Biology, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Qld 4072, Australia
*To whom correspondence should be addressed. For P.V.B. (chemistry): phone, +61-7-3365-4266; fax, +61-7-3365-4299; e-mail, [email protected]. For D.R.R. (biology and chemistry): phone, +61-2-9036-6548; fax, +61-2-9036-6549; e-mail, [email protected]
§P.V.B. and D.R.R. contributed equally as senior authors.
Cite this: J. Med. Chem. 2010, 53, 15, 5759–5769
Publication Date (Web):July 2, 2010
Copyright © 2010 American Chemical Society

    Article Views





    Other access options
    Supporting Info (1)»


    Abstract Image

    The novel chelators 2-acetylpyridine-4,4-dimethyl-3-thiosemicarbazone (HAp44mT) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (HDp44mT) have been examined to elucidate the structure−activity relationships necessary to form copper (Cu) complexes with pronounced antitumor activity. Electrochemical studies demonstrated that the Cu complexes of these ligands had lower redox potentials than their iron complexes. Moreover, the Cu complexes where the ligand/metal ratio was 1:1 rather than 2:1 had significantly higher intracellular oxidative properties and antitumor efficacy. Interestingly, the 2:1 complex was shown to dissociate to give significant amounts of the 1:1 complex that could be the major cytotoxic effector. Both types of Cu complex showed significantly more antiproliferative activity than the ligand alone. We also demonstrate the importance of the inductive effects of substituents on the carbonyl group of the parent ketone, which influence the CuII/I redox potentials because of their proximity to the metal center. The structure−activity relationships described are important for the design of potent thiosemicarbazone Cu complexes.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    Jump To

    Simulated and experimental EPR spectra including spin Hamiltonian parameters. This material is available free of charge via the Internet at

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 196 publications.

    1. Shihang Xu, Weicong Luo, Minghui Zhu, Lei Zhao, Lijuan Gao, Hong Liang, Zhenlei Zhang, Feng Yang. Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment. Molecular Pharmaceutics 2024, 21 (1) , 346-357.
    2. Tharushi P. Wijesinghe, Busra Kaya, Miguel A. Gonzálvez, Jeffrey R. Harmer, Mahan Gholam Azad, Paul V. Bernhardt, Mahendiran Dharmasivam, Des R. Richardson. Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series. Journal of Medicinal Chemistry 2023, 66 (22) , 15453-15476.
    3. Nerina Shahi, Paras Nath Yadav, Upendra Chaudhary, Mohd Saad, Kuldeep Mahiya, Arif Khan, Syed Shafi, Yuba Raj Pokharel. 5-Methoxyisatin N(4)-Pyrrolidinyl Thiosemicarbazone (MeOIstPyrd) Restores Mutant p53 and Inhibits the Growth of Skin Cancer Cells, In Vitro. ACS Omega 2023, 8 (35) , 31998-32016.
    4. Juzheng Zhang, Ronghao Fang, Yanping Li, Jiamin Jin, Feng Yang, Jian Chen. Encapsulation of Au(III) Complex Using Lactoferrin Nanoparticles to Combat Glioma. Molecular Pharmaceutics 2023, 20 (7) , 3632-3644.
    5. Zhenlei Zhang, Juzheng Zhang, Tongfu Yang, Shanhe Li, Gang Xu, Hong Liang, Feng Yang. Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin. Journal of Medicinal Chemistry 2023, 66 (8) , 5669-5684.
    6. Mahendiran Dharmasivam, Busra Kaya, Tharushi Wijesinghe, Mahan Gholam Azad, Miguel A. Gonzálvez, Mohammad Hussaini, Jason Chekmarev, Paul V. Bernhardt, Des R. Richardson. Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel “Stealth Zinc(II) Complex”. Journal of Medicinal Chemistry 2023, 66 (2) , 1426-1453.
    7. Juzheng Zhang, Ming Jiang, Shanhe Li, Zhenlei Zhang, Hongbin Sun, Feng Yang, Hong Liang. Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy. Journal of Medicinal Chemistry 2021, 64 (10) , 6777-6791.
    8. Juzheng Zhang, Zhenlei Zhang, Ming Jiang, Shanhe Li, Haoliang Yuan, Hongbin Sun, Feng Yang, Hong Liang. Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis. Journal of Medicinal Chemistry 2020, 63 (22) , 13695-13708.
    9. Julia H. Bormio Nunes, Sonja Hager, Marlene Mathuber, Vivien Pósa, Alexander Roller, Éva A. Enyedy, Alessia Stefanelli, Walter Berger, Bernhard K. Keppler, Petra Heffeter, Christian R. Kowol. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. Journal of Medicinal Chemistry 2020, 63 (22) , 13719-13732.
    10. Zhenlei Zhang, Juzheng Zhang, Ming Jiang, Lei Zhao, Shanhe Li, Hongbin Sun, Feng Yang, Hong Liang. Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment. Molecular Pharmaceutics 2020, 17 (4) , 1405-1414.
    11. Elizabeth W. Hunsaker, Katherine J. Franz. Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit. Inorganic Chemistry 2019, 58 (20) , 13528-13545.
    12. Rukhsana Anjum, Duraippandi Palanimuthu, Danuta S. Kalinowski, William Lewis, Kyung Chan Park, Zaklina Kovacevic, Irfan Ullah Khan, Des R. Richardson. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes. Inorganic Chemistry 2019, 58 (20) , 13709-13723.
    13. Alexandra E. Stacy, Duraippandi Palanimuthu, Paul V. Bernhardt, Danuta S. Kalinowski, Patric J. Jansson, and Des R. Richardson . Structure–Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance. Journal of Medicinal Chemistry 2016, 59 (18) , 8601-8620.
    14. Jinxu Qi, Yi Gou, Yao Zhang, Kun Yang, Shifang Chen, Li Liu, Xiaoyang Wu, Tao Wang, Wei Zhang, and Feng Yang . Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain. Journal of Medicinal Chemistry 2016, 59 (16) , 7497-7511.
    15. Christian R. Kowol, Walter Miklos, Sarah Pfaff, Sonja Hager, Sebastian Kallus, Karla Pelivan, Mario Kubanik, Éva A. Enyedy, Walter Berger, Petra Heffeter, and Bernhard K. Keppler . Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention. Journal of Medicinal Chemistry 2016, 59 (14) , 6739-6752.
    16. Alexandra E. Stacy, Duraippandi Palanimuthu, Paul V. Bernhardt, Danuta S. Kalinowski, Patric J. Jansson, and Des R. Richardson . Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity. Journal of Medicinal Chemistry 2016, 59 (10) , 4965-4984.
    17. Zaynab Al-Eisawi, Christian Stefani, Patric J. Jansson, Akanksha Arvind, Philip C. Sharpe, Maram T. Basha, George M. Iskander, Naresh Kumar, Zaklina Kovacevic, Darius J. R. Lane, Sumit Sahni, Paul V. Bernhardt, Des R. Richardson, and Danuta S. Kalinowski . Novel Mechanism of Cytotoxicity for the Selective Selenosemicarbazone, 2-Acetylpyridine 4,4-Dimethyl-3-selenosemicarbazone (Ap44mSe): Lysosomal Membrane Permeabilization. Journal of Medicinal Chemistry 2016, 59 (1) , 294-312.
    18. Yi Gou, Jinxu Qi, Joshua-Paul Ajayi, Yao Zhang, Zuping Zhou, Xiaoyang Wu, Feng Yang, and Hong Liang . Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain. Molecular Pharmaceutics 2015, 12 (10) , 3597-3609.
    19. May Lee Low, Laure Maigre, Pierre Dorlet, Régis Guillot, Jean-Marie Pagès, Karen A. Crouse, Clotilde Policar, and Nicolas Delsuc . Conjugation of a New Series of Dithiocarbazate Schiff Base Copper(II) Complexes with Vectors Selected to Enhance Antibacterial Activity. Bioconjugate Chemistry 2014, 25 (12) , 2269-2284.
    20. Carlo Santini, Maura Pellei, Valentina Gandin, Marina Porchia, Francesco Tisato, and Cristina Marzano . Advances in Copper Complexes as Anticancer Agents. Chemical Reviews 2014, 114 (1) , 815-862.
    21. Felix Bacher, Éva A. Enyedy, Nóra V. Nagy, Antal Rockenbauer, Gabriella M. Bognár, Robert Trondl, Maria S. Novak, Erik Klapproth, Tamás Kiss, and Vladimir B. Arion . Copper(II) Complexes with Highly Water-Soluble l- and d-Proline–Thiosemicarbazone Conjugates as Potential Inhibitors of Topoisomerase IIα. Inorganic Chemistry 2013, 52 (15) , 8895-8908.
    22. Duraippandi Palanimuthu, Sridevi Vijay Shinde, Kumaravel Somasundaram, and Ashoka G. Samuelson . In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes. Journal of Medicinal Chemistry 2013, 56 (3) , 722-734.
    23. Miljan N. M. Milunovic, Éva A. Enyedy, Nóra V. Nagy, Tamás Kiss, Robert Trondl, Michael A. Jakupec, Bernhard K. Keppler, Regina Krachler, Ghenadie Novitchi, and Vladimir B. Arion . l- and d-Proline Thiosemicarbazone Conjugates: Coordination Behavior in Solution and the Effect of Copper(II) Coordination on Their Antiproliferative Activity. Inorganic Chemistry 2012, 51 (17) , 9309-9321.
    24. David B. Lovejoy, Danae M. Sharp, Nicole Seebacher, Peyman Obeidy, Thomas Prichard, Christian Stefani, Maram T. Basha, Philip C. Sharpe, Patric J. Jansson, Danuta S. Kalinowski, Paul V. Bernhardt, and Des R. Richardson . Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo. Journal of Medicinal Chemistry 2012, 55 (16) , 7230-7244.
    25. Ruchi Gaur and Lallan Mishra . Synthesis and Characterization of Ru(II)–DMSO–Cl–Chalcone Complexes: DNA Binding, Nuclease, and Topoisomerase II Inhibitory Activity. Inorganic Chemistry 2012, 51 (5) , 3059-3070.
    26. Brian M. Zeglis, Vadim Divilov, and Jason S. Lewis . Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II) Complexes. Journal of Medicinal Chemistry 2011, 54 (7) , 2391-2398.
    27. Duaa R. Alajroush, Chloe B. Smith, Brittney F. Anderson, Ifeoluwa T. Oyeyemi, Stephen J. Beebe, Alvin A. Holder. A comparison of in vitro studies between cobalt(III) and copper(II) complexes with thiosemicarbazone ligands to treat triple negative breast cancer. Inorganica Chimica Acta 2024, 562 , 121898.
    28. Iman Doumi, Lukas Lang, Bertrand Vileno, Marcel Deponte, Peter Faller. Glutathione Protects other Cellular Thiols against Oxidation by Cu II ‐Dp44mT. Chemistry – A European Journal 2024, 9
    29. Mahendiran Dharmasivam, Busra Kaya, Tharushi P. Wijesinghe, Vera Richardson, Jeffrey R. Harmer, Miguel A. Gonzalvez, William Lewis, Mahan Gholam Azad, Paul V. Bernhardt, Des R. Richardson. Differential transmetallation of complexes of the anti-cancer thiosemicarbazone, Dp4e4mT: effects on anti-proliferative efficacy, redox activity, oxy-myoglobin and oxy-hemoglobin oxidation. Chemical Science 2024, 15 (3) , 974-990.
    30. Iman K. Al-Salmi, Musa S. Shongwe. Ternary Phenolate-Based Thiosemicarbazone Complexes of Copper(II): Magnetostructural Properties, Spectroscopic Features and Marked Selective Antiproliferative Activity against Cancer Cells. Molecules 2024, 29 (2) , 431.
    31. Alondra Jiménez-Pérez, Sandra Fernández-Fariña, Rosa Pedrido, Javier García-Tojal. Desulfurization of thiosemicarbazones: the role of metal ions and biological implications. JBIC Journal of Biological Inorganic Chemistry 2023, 39
    32. Kakoli Malakar, Balasubramaniam Selvakumaran, Mariappan Murali, Pitchan Arul Prakash, Somasundaram Sangeetha, Winaki P. Sohtun, Mohamed Sultan Mohamed Jaabir, Marappan Velusamy. Copper( ii ) complexes of the CuN 4 S core: selective cytotoxicity to cancerous cells, ROS generation and induction of apoptosis. New Journal of Chemistry 2023, 47 (43) , 20070-20087.
    33. Ying Yang, Man Li, Gang Chen, Suyi Liu, Houqi Guo, Xiongwei Dong, Kai Wang, Hongen Geng, Jun Jiang, Xiang Li. Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’. Coordination Chemistry Reviews 2023, 495 , 215395.
    34. Muhammad Hamza Ashfaq. Synthesis and Anticancer Activity of Bis-Thiosemicarbazone Complexes. Asian Journal of Pharmaceutical Research 2023, , 181-185.
    35. Swarup Kumar Tarai, Saikat Mandal, Arup Tarai, Ipsita Som, Angana Pan, Arka Bagchi, Arunima Biswas, Sankar Ch. Moi. Biophysical study on DNA and BSA binding activity of Cu(II) complex: Synthesis, molecular docking, cytotoxic activity, and theoretical approach. Applied Organometallic Chemistry 2023, 37 (8)
    36. Martin Schaier, Enrico Falcone, Tomas Prstek, Bertrand Vileno, Sonja Hager, Bernhard K Keppler, Petra Heffeter, Gunda Koellensperger, Peter Faller, Christian R Kowol. Human serum albumin as a copper source for anticancer thiosemicarbazones. Metallomics 2023, 15 (8)
    37. Kexuan Liu, Lei Huang, Shuangyan Qi, Shuchen Liu, Wangni Xie, Liuyi Du, Jing Cui, Xu Zhang, Boya Zhang, Lijun Liu, Daowei Li, Hongchen Sun. Ferroptosis: The Entanglement between Traditional Drugs and Nanodrugs in Tumor Therapy. Advanced Healthcare Materials 2023, 12 (12)
    38. Muhammad Hanif, Awal Noor, Mian Muhammad, Farhat Ullah, Muhammad Nawaz Tahir, Gul Shahzada Khan, Ezzat Khan. Complexes of 2-Amino-3-methylpyridine and 2-Amino-4-methylbenzothiazole with Ag(I) and Cu(II): Structure and Biological Applications. Inorganics 2023, 11 (4) , 152.
    39. Narjala Rama Jyothi, Snehalatha Pulivarthi. Cytotoxic Activity of Schiff Bases and Their Complexes. 2023
    40. Yunyun Zheng, Kai Wei, Yingying Gao, Ziyan Zhou, Xinhua Zheng, Jiuling Li, Jinxu Qi. Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes. Journal of Inorganic Biochemistry 2023, 240 , 112116.
    41. Priyatosh Nath, Abhijit Datta, Suman Adhikari. Recent Advances of Metal-Based Anticancer Agents and Their In Vivo Potential Against Various Types of Malignancies. 2023, 917-943.
    42. Ali G. Al-Dulimi, Ahmed Fadhil Naema, Zahraa K. Zedan, Ibrahim Hadi Mohammed, Abeer M. Jabar, Maryam Hekmat Abdulateef. RGD-coupled gold nanoparticles initiate apoptosis in human cancer cells. 2023, 020015.
    43. Alondra Jiménez-Pérez, Sara Marcos-Gómez, Gotzon Madariaga, Manuel Zapico, Pablo Vitoria, Javier Tercero, M. Begoña Torres, Luis Lezama, José Vicente Cuevas, Iñigo Etxebarria, Javier García-Tojal. Thiosemicarbazonecopper/Halido Systems: Structure and DFT Analysis of the Magnetic Coupling. Inorganics 2023, 11 (1) , 31.
    44. Ali A.A. Al-Riyahee, Peter N. Horton, Simon J. Coles, Angelo J. Amoroso, Simon J. A. Pope. Ni(II), Cu(II) and Zn(II) complexes of functionalised thiosemicarbazone ligands: Syntheses and reactivity, characterization and structural studies. Polyhedron 2022, 225 , 116079.
    45. Ilknur Babahan‐Bircan, Safiye Emirdağ, Ali Özmen, Mürüvvet Abbak, Oguejiofo T. Ujam, Ilke Demirkaya, M. Emin Günay. A new hybrid ligand and its metal complexes from a natural plant ( Styrax officinalis ) bearing egonol, thiosemicarbazone and oxime units, and their anti‐cancer activities. Applied Organometallic Chemistry 2022, 36 (9)
    46. Jaehee Kim, Areum Park, Jieon Hwang, Xianghua Zhao, Jaesung Kwak, Hyun Woo Kim, Minhee Ku, Jaemoon Yang, Tae Il Kim, Kyu-Sung Jeong, Uyeong Choi, Hyuk Lee, Sang Joon Shin. KS10076, a chelator for redox-active metal ions, induces ROS-mediated STAT3 degradation in autophagic cell death and eliminates ALDH1+ stem cells. Cell Reports 2022, 40 (3) , 111077.
    47. E. H. Edinsha Gladis, K. Nagashri, A. Krishnendu. Synthesis, structural elucidation, DNA binding, cleavage, AChE and BuChE cholinesterase efficiencies of metal complexes with 1,10-phenanthroline scaffold. Nucleosides, Nucleotides & Nucleic Acids 2022, 41 (3) , 285-313.
    48. Bekesho Geleta, Faten S. Tout, Syer Choon Lim, Sumit Sahni, Patric J. Jansson, Minoti V. Apte, Des R. Richardson, Žaklina Kovačević. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. Journal of Biological Chemistry 2022, 298 (3) , 101608.
    49. Priyatosh Nath, Abhijit Datta, Suman Adhikari. Recent Advances of Metal-Based Anticancer Agents and Their In Vivo Potential Against Various Types of Malignancies. 2022, 1-28.
    50. Tarlok Singh Lobana, Mani Kaushal, Ritu Bala, Isabel Garcia-Santos, Jerry P. Jasinski. Copper(I) derivatives of 4-benzoylpyridine thiosemicarbazone and 3-formylpyridine-N-methylthiosemicarbazone with triphenylphosphine as a co-ligand. Journal of the Indian Chemical Society 2022, 99 (1) , 100298.
    51. Daniela Almeida da Silva, Anastasia De Luca, Rosanna Squitti, Mauro Rongioletti, Luisa Rossi, Camila M.L. Machado, Giselle Cerchiaro. Copper in tumors and the use of copper-based compounds in cancer treatment. Journal of Inorganic Biochemistry 2022, 226 , 111634.
    52. Tarlok Singh Lobana, Mani Kaushal, Robin Bhatia, Ritu Bala, Ray J. Butcher, Jerry P. Jasinksi. Crystal structures of 3/4-pyridyl-based thiosemicarbazones and related Cu and Ni coordination compounds. Acta Crystallographica Section C Structural Chemistry 2022, 78 (1) , 30-35.
    53. B. Ebenezer, K. Nagashri. Synthesis and in vitro biochemical properties, DNA binding and DNA cleavage ability of copper complexes of hydroxyflavone derivatives of novel organosulfur compounds as therapeutic agent. Nucleosides, Nucleotides & Nucleic Acids 2021, 40 (12) , 1159-1197.
    54. Tharushi P. Wijesinghe, Mahendiran Dharmasivam, Charles C. Dai, Des R. Richardson. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc. Pharmacological Research 2021, 173 , 105889.
    55. Jason Chekmarev, Mahan Gholam Azad, Des R. Richardson. The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity. Cells 2021, 10 (9) , 2382.
    56. Adolfo I. B. Romo, Marta P. Carepo, Pedro Levín, Otaciro R. Nascimento, Daniel E. Díaz, Joaquín Rodríguez-López, Ignácio E. León, Lucas F. Bezerra, Luis Lemus, Izaura C. N. Diógenes. Synergy of DNA intercalation and catalytic activity of a copper complex towards improved polymerase inhibition and cancer cell cytotoxicity. Dalton Transactions 2021, 50 (34) , 11931-11940.
    57. Maria V. Babak, Dohyun Ahn. Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance. Biomedicines 2021, 9 (8) , 852.
    58. Tarlok S. Lobana, Shikha Indoria, Henna Sood, Daljit S. Arora, Geeta Hundal, Jerry P. Jasinski. Synthesis and structures of 3-nitro-salicylaldehyde-N-substituted thiosem-icarbazonates of copper(II): Novel bio-active materials against E. faecalis, E. coli, and K. pneumoniae. Inorganica Chimica Acta 2021, 521 , 120334.
    59. Chengfeng Bai, Shuangjie Wu, Shengnan Ren, Meiqi Zhu, Guoshun Luo, Hua Xiang. Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer. Bioorganic & Medicinal Chemistry 2021, 37 , 116107.
    60. Enis Nadia Md Yusof, Thahira B.S.A. Ravoof, Alister J. Page. Cytotoxicity of Tin(IV)-based compounds: A review. Polyhedron 2021, 198 , 115069.
    61. Bekesho Geleta, Kyung Chan Park, Patric J. Jansson, Sumit Sahni, Sanaz Maleki, Zhihong Xu, Takashi Murakami, Marina Pajic, Minoti V. Apte, Des R. Richardson, Zaklina Kovacevic. Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma. The FASEB Journal 2021, 35 (2)
    62. Safaa I. Elewa, Abdou O. Abdelhamid, Ahmed A. Hamed, Eman Mansour. Synthesis, characterization, antimicrobial activities, anticancer of some new pyridines from 2, 3-dihydro-2-oxo-4-phenyl-6-(thien-2-yl) pyridine-3-carbonitrile. Synthetic Communications 2021, 51 (1) , 151-161.
    63. S. Baskaran, M.Murali Krishnan, M.N. Arumugham, Rakesh Kumar. Synthesis, crystal structure, DNA interaction, DFT analysis and molecular docking studies of copper(ii) complexes with 1-methyl-l-tryptophan and phenanthroline units. Journal of Molecular Structure 2021, 1224 , 129236.
    64. S. Krishan, S. Sahni, D.R. Richardson. The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020, 1866 (12) , 165970.
    65. Rui-Feng Guo, Hou-Tian Yan, Rui-Xue Liu, Hong-Chang Li, Yan-Cheng Liu, Zhen-Feng Chen, Hong Liang. Structural characterization and pharmacological assessment in vitro / in vivo of a new copper( ii )-based derivative of enrofloxacin. Metallomics 2020, 12 (12) , 2145-2160.
    66. Valentina Oliveri. Biomedical applications of copper ionophores. Coordination Chemistry Reviews 2020, 422 , 213474.
    67. Tarlok S. Lobana, Mani Kaushal, Ritu Bala, Lovedeep Nim, Kamaldeep Paul, Daljit S. Arora, Astha Bhatia, Saroj Arora, Jerry P. Jasinski. Di-2-pyridylketone-N1-substituted thiosemicarbazone derivatives of copper(II): Biosafe antimicrobial potential and high anticancer activity against immortalized L6 rat skeletal muscle cells. Journal of Inorganic Biochemistry 2020, 212 , 111205.
    68. Ali G. Al-Dulimi, Ali Z. Al-Saffar, Ghassan M. Sulaiman, Khalil A.A. Khalil, Khawla S. Khashan, Hanady S.A. Al-Shmgani, Elsadig M. Ahmed. Immobilization of l-asparaginase on gold nanoparticles for novel drug delivery approach as anti-cancer agent against human breast carcinoma cells. Journal of Materials Research and Technology 2020, 9 (6) , 15394-15411.
    69. Ali G. Al-Dulimi, Ali Z. Al-Saffar, Ghassan M. Sulaiman. Enhanced cellular uptake and anti-cancer potentials of gold nanoparticles conjugated with cell penetration peptide against lung cancer cells. IOP Conference Series: Materials Science and Engineering 2020, 928 (6) , 062025.
    70. Qian Zhang, Zhenzhen Li, Jiacheng Liu. Applying Cu(II) complexes assisted by water‐soluble porphyrin to DNA binding and selective anticancer activities. Applied Organometallic Chemistry 2020, 34 (10)
    71. Narendra Kumar Singh, Anupa A Kumbhar, Yuba Raj Pokharel, Paras Nath Yadav. Anticancer potency of copper(II) complexes of thiosemicarbazones. Journal of Inorganic Biochemistry 2020, 210 , 111134.
    72. Miljan N. M. Milunović, Oleg Palamarciuc, Angela Sirbu, Sergiu Shova, Dan Dumitrescu, Dana Dvoranová, Peter Rapta, Tatsiana V. Petrasheuskaya, Eva A. Enyedy, Gabriella Spengler, Marija Ilic, Harald H. Sitte, Gert Lubec, Vladimir B. Arion. Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters. Biomolecules 2020, 10 (9) , 1213.
    73. Kateryna Ohui, Iryna Stepanenko, Iuliana Besleaga, Maria V. Babak, Radu Stafi, Denisa Darvasiova, Gerald Giester, Vivien Pósa, Eva A. Enyedy, Daniel Vegh, Peter Rapta, Wee Han Ang, Ana Popović-Bijelić, Vladimir B. Arion. Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells. Biomolecules 2020, 10 (9) , 1336.
    74. Kyung Chan Park, Mahendiran Dharmasivam, Des R. Richardson. The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators That Inhibit Their Activity. International Journal of Molecular Sciences 2020, 21 (18) , 6805.
    75. Sonja Hager, Veronika F.S. Pape, Vivien Pósa, Bianca Montsch, Lukas Uhlik, Gergely Szakács, Szilárd Tóth, Nikolett Jabronka, Bernhard K. Keppler, Christian R. Kowol, Éva A. Enyedy, Petra Heffeter. High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones. Antioxidants & Redox Signaling 2020, 33 (6) , 395-414.
    76. Sumit Sahni, Josef Gillson, Kyung Chan Park, Shannon Chiang, Lionel Yi Wen Leck, Patric J. Jansson, Des R. Richardson. NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization. Biochimica et Biophysica Acta (BBA) - General Subjects 2020, 1864 (8) , 129625.
    77. Bhushan Shakya, Paras Nath Yadav. Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action. Mini-Reviews in Medicinal Chemistry 2020, 20 (8) , 638-661.
    78. S. Krishan, S. Sahni, L.Y.W. Leck, P.J. Jansson, D.R. Richardson. Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020, 1866 (5) , 165657.
    79. Mauro Carcelli, Matteo Tegoni, Jennifer Bartoli, Cristina Marzano, Giorgio Pelosi, Marika Salvalaio, Dominga Rogolino, Valentina Gandin. In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target. European Journal of Medicinal Chemistry 2020, 194 , 112266.
    80. Raquel Alcaraz, Pilar Muñiz, Mónica Cavia, Óscar Palacios, Katia G. Samper, Rubén Gil-García, Alondra Jiménez-Pérez, Javier García-Tojal, Carlos García-Girón. Thiosemicarbazone-metal complexes exhibiting cytotoxicity in colon cancer cell lines through oxidative stress. Journal of Inorganic Biochemistry 2020, 206 , 110993.
    81. Jinxu Qi, Xuejiao Wang, Taichen Liu, Martha Kandawa-Schulz, Yihong Wang, Xinhua Zheng. Synthesis, antiproliferative activity and mechanism of copper(II)-thiosemicarbazone complexes as potential anticancer and antimicrobial agents. Journal of Coordination Chemistry 2020, 73 (7) , 1208-1221.
    82. Daniel L. Sun, Soumya Poddar, Roy D. Pan, Ethan W. Rosser, Evan R. Abt, Juno Van Valkenburgh, Thuc M. Le, Vincent Lok, Selena P. Hernandez, Janet Song, Joanna Li, Aneta Turlik, Xiaohong Chen, Chi-An Cheng, Wei Chen, Christine E. Mona, Andreea D. Stuparu, Laurent Vergnes, Karen Reue, Robert Damoiseaux, Jeffrey I. Zink, Johannes Czernin, Timothy R. Donahue, Kendall N. Houk, Michael E. Jung, Caius G. Radu. Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias. RSC Medicinal Chemistry 2020, 11 (3) , 392-410.
    83. Tatyana V. Berestova, Sergey L. Khursan, Akhat G. Mustafin. Experimental and theoretical substantiation of differences of geometric isomers of copper(II) α-amino acid chelates in ATR-FTIR spectra. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020, 229 , 117950.
    84. Sven Marcel Stefan, Patric J Jansson, Danuta S Kalinowski, Rukhsana Anjum, Mahendiran Dharmasivam, Des R Richardson. The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance. Future Medicinal Chemistry 2020, 12 (6) , 473-477.
    85. Alireza Habibi, Seyed Ataollah Sadat Shandiz, Ali salehzadeh, Zeinab Moradi-Shoeili. Novel pyridinecarboxaldehyde thiosemicarbazone conjugated magnetite nanoparticulates (MNPs) promote apoptosis in human lung cancer A549 cells. JBIC Journal of Biological Inorganic Chemistry 2020, 25 (1) , 13-22.
    86. Stephen J. Beebe, Michael J. Celestine, Jimmie L. Bullock, Shayna Sandhaus, Jessa Faye Arca, Donald M. Cropek, Tekettay A. Ludvig, Sydney R. Foster, Jasmine S. Clark, Floyd A. Beckford, Criszcele M. Tano, Elizabeth A. Tonsel-White, Raj K. Gurung, Courtney E. Stankavich, Yuk-Ching Tse-Dinh, William L. Jarrett, Alvin A. Holder. Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand. Journal of Inorganic Biochemistry 2020, 203 , 110907.
    87. Haiyan Zhao, Jie Li, Yan Fang, Bowen Chang, Qingxi Meng, Mingxue Li, Chunzhang Wang, Xianfeng Zhu. Synthesis, characterization and bioactivities of a new covalent copper(II) compound derived from {P2Mo5O23}6− and thiosemicarbazones. Bioorganic & Medicinal Chemistry Letters 2020, 30 (1) , 126781.
    88. Orsolya Dömötör, Márton A. Kiss, G. Tamás Gál, Nóra V. May, Gabriella Spengler, Márta Nové, Ana Čipak Gašparović, Éva Frank, Éva A. Enyedy. Solution equilibrium, structural and cytotoxicity studies on Ru(η6-p-cymene) and copper complexes of pyrazolyl thiosemicarbazones. Journal of Inorganic Biochemistry 2020, 202 , 110883.
    89. Soheila Jenabi Sardroud, Seyed Abolfazl Hosseini-Yazdi, Majid Mahdavi, Morgane Poupon, Eliska Skorepova. Synthesis, characterization and in vitro evaluation of anticancer activity of a new water-soluble thiosemicarbazone ligand and its complexes. Polyhedron 2020, 175 , 114218.
    90. Jessica L. Chitty, Yordanos F.I. Setargew, Thomas R. Cox. Targeting the lysyl oxidases in tumour desmoplasia. Biochemical Society Transactions 2019, 47 (6) , 1661-1678.
    91. Sunil K. Pandey, Durga P. Singh, Seema Pratap, Gaetano Marverti, R.J. Butcher. Copper(I) complexes of N-(2/4 methoxy/2-chloro-4-nitro)phenyl-N′ (methoxycarbonyl)thiocarbamides as potential anticancer agents: Synthesis, crystal structure, in vitro cytotoxicity and DNA damage studies. Polyhedron 2019, 170 , 431-439.
    92. Kabir Mody, Aaron S. Mansfield, Lalitha Vemireddy, Peter Nygren, Joachim Gulbo, Mitesh Borad. A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors. Investigational New Drugs 2019, 37 (4) , 684-692.
    93. Ping Yu, Jungang Deng, Jinhua Cai, Zhenlei Zhang, Juzheng Zhang, Muhammad Hamid Khan, Hong Liang, Feng Yang. Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex. Metallomics 2019, 11 (8) , 1372-1386.
    94. Mani Kaushal, Tarlok S. Lobana, Lovedeep Nim, Ritu Bala, Daljit S. Arora, Isabel Garcia-Santos, Courtney E. Duff, Jerry P. Jasinski. Synthesis of 2-acetylpyridine- N -substituted thiosemicarbazonates of copper( ii ) with high antimicrobial activity against methicillin resistant S. aureus , K. pneumoniae 1 and C. albicans. New Journal of Chemistry 2019, 43 (29) , 11727-11742.
    95. Jhi Biau Foo, Li Shan Ng, Ji Hui Lim, Pau Xien Tan, Yan Zhi Lor, Jason Siau Ee Loo, May Lee Low, Lee Chin Chan, Chaw Yee Beh, Sze Wei Leong, Latifah Saiful Yazan, Yin Sim Tor, Chee Wun How. Induction of cell cycle arrest and apoptosis by copper complex Cu(SBCM) 2 towards oestrogen-receptor positive MCF-7 breast cancer cells. RSC Advances 2019, 9 (32) , 18359-18370.
    96. Anna Mrozek-Wilczkiewicz, Katarzyna Malarz, Marta Rejmund, Jaroslaw Polanski, Robert Musiol. Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety. European Journal of Medicinal Chemistry 2019, 171 , 180-194.
    97. Sunil K. Pandey, Seema Pratap, Sandeep Pokharia, Hirdyesh Mishra, Gaetano Marverti, Manpreet Kaur, Jerry P. Jasinski. Copper (I) complexes based on novel N, N′-disubstituted thiocarbamides: Synthesis, spectroscopic, in vitro cytotoxicity, DNA damage and G0/G1 cell cycle arrest studies. Inorganica Chimica Acta 2019, 491 , 105-117.
    98. Alice Santoro, Bertrand Vileno, Òscar Palacios, Manuel David Peris-Díaz, Gilles Riegel, Christian Gaiddon, Artur Krężel, Peter Faller. Reactivity of Cu( ii )–, Zn( ii )– and Fe( ii )–thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation. Metallomics 2019, 11 (5) , 994-1004.
    99. Claudia C. Gatto, Marcio A. S. Chagas, Iariane J. Lima, Francyelli Mello Andrade, Hugo D. Silva, Gabrielly R. Abrantes, Elisângela P. S. Lacerda. Copper(II) complexes with pyridoxal dithiocarbazate and thiosemicarbazone ligands: crystal structure, spectroscopic analysis and cytotoxic activity. Transition Metal Chemistry 2019, 44 (4) , 329-340.
    100. Leyla Fouani, Zaklina Kovacevic, Des R. Richardson. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment. Antioxidants & Redox Signaling 2019, 30 (8) , 1096-1123.
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect